HK Stock Market Move | BIOHEART-B(02185) once rose more than 15%, closed up over 50% yesterday, RDN entered the American hypertension guidelines.

BIOHEART-B(02185) rose more than 15% at one point, and closed up over 50% yesterday. As of the time of publication, it has risen by 11.4%, to 10.36 Hong Kong dollars, with a turnover of 42.644 million Hong Kong dollars. On the news front, in recent days, several institutions including the American Heart Association (AHA) and the American College of Cardiology (ACC) jointly released updated guidelines for the prevention, detection, assessment, and management of adult hypertension, revising the guidelines from 2017. The new guidelines have updates in the diagnosis, risk assessment, and treatment of hypertension, aiming to provide more accurate guidance for clinical practice and reduce the risk of cardiovascular diseases (CVD). Among them, Renal Denervation (RDN) has become a newly recommended treatment. Also worth noting is that there have been reports that the Centers for Medicare & Medicaid Services (CMS) in the United States have issued a new Medicare proposal for RDN. The new proposal suggests including RDN in the Medicare coverage for patients with uncontrolled hypertension. The proposal has initiated a 30-day public comment period, and the final decision is expected to be announced by October 8, 2025, or earlier.